Gland Pharma Limited has informed the Exchange about Link of Recording
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gland Pharma has notified the stock exchanges that the Q4 FY26 earnings call held on May 15, 2026 has been recorded and uploaded to the company website. This is a routine regulatory compliance filing under SEBI LODR Regulations 30 and 46. The disclosure provides investors direct access to the audio recording of the earnings call for the quarter and financial year ended March 31, 2026. No new financial information, guidance, or material announcements are contained in this filing itself.
No direct stock impact - this filing merely provides access to an already-held earnings call recording. Investors who want to review management commentary on Q4 FY26 results can now listen to the full call.